Petauri PACT Executive Briefings - 3-Minute Market Insights
Welcome to the Petauri PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights.
Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery.
I’m Dr. Warren Smedley, thank you for joining us.
Petauri PACT Executive Briefings - 3-Minute Market Insights
Cardio-Oncology: Addressing Cardio-Toxicities from Cancer Treatment
Cardio-Oncology: Addressing Cardio-Toxicities from Cancer Treatment
Cancer treatments have improved significantly over the last 40 years, with much improved outcomes for 5-year survival. In 1975, a cancer diagnosis came with a projected overall 5-year survival rate of less than a 50%. Today, the overall five-year survival rate is close to 70%, and for some disease groups, like breast cancer, the rate is much higher, especially if detected at an early stage. Cancer treatments have the potential to be hard on other organs of the body and some are especially hard on the heart and vascular systems. Many drug therapies, as well as radiation therapy, can have negative long term effects on the heart, if not managed correctly. Cardio-Oncologists bridge the gap between the oncologist and the cardiologist, to help prevent and/or manage the long term effects of cancer treatments on the heart.